So the first step is assessing what is the next best option for the patient. And this involves, as you noted, a combination of specialists, who can provide different sorts of therapy to a patient to treat their lung cancer. One thing to consider upfront is whether we can use a definitiv...
It can also relieve some of the symptoms of lung cancer, such as pain or bleeding. Chemotherapy These medicines kill cancer cells in the body. It’s an option for bothtypes of lung cancer. You might getchemobefore or after surgery, combined with radiation therapy. Or it might be your mai...
The new guidelines aims to offer clinicians and their patients more options for the treatment of advanced disease. The changes focused on issues relevant to the principles of chemotherapy. In the new guidelines,...
Biopsy is another option to check the cells growing in the lungs, whereas thoracentesis can check the fluid around the lungs to see whether it is cancerous.1,3 Treatment options for patients with lung cancer may include surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, ...
21 In 2021, the National Comprehensive Cancer Network (NCCN) guidelines highlighted the combination of atezolizumab and bevacizumab as the preferred first-line treatment option for patients with hepatocellular carcinoma (HCC).22 This recommendation underscores the importance of immunotherapy and anti-...
As treatment if your lung cancer has spread to other parts of the body (metastatic) Your doctor will perform a test to make sure that ALECENSA is right for you. It is not known if ALECENSA is safe and effective in children. What is the most important information I should know about ALEC...
Non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutation and concurrent mutations have a poor prognosis. This study aimed to examine anlotinib plus icotinib as a first-line treatment option for advanced NSCLC carrying EGFR mutation with or without concurrent ...
Lung cancer is the second most common cancer in the UK, accounting for one in seven new cases, 24% of cancer deaths among men and 20% among women.1 In this article, Dr Fiona Blackhall and Steve Chaplin consider the use of gefitinib for lung cancer its mechanism of action, efficacy and...
Second-line treatment options for patients with relapsed, extensive-stage small cell lung cancer (ES-SCLC) are limited, and even with currently available treatments, prognosis remains poor. Until recently, topotecan (a topoisomerase I inhibitor) was the only drug approved by the United States (US...
Smoking is the biggest risk factor for lung cancer. Lungcanceris a group of diseases characterized by abnormal growths (cancers) that started in the lungs. People should seek medical care if they have blood in their sputum whencoughing, are experiencing unexplainedweight loss, or have sudden sho...